Liposomal Bupivacaine vs Peripheral Nerve Block
Stopped early · Phase 4
Conditions studied: Pain, Acute, Surgery, Anesthesia, Opioid Use
In brief
Liposomal bupivacaine has gained interest in recent literature for its potential to be an effective adjunct to other pain control modalities in a multi-modal approach to post-operative pain control. The goal of this investigation is to compare the efficacy of local administration of liposomal bupivacaine versus the efficacy of a peripheral nerve block in terms of post-operative pain scores after elective ankle and hindfoot surgery. The investigators hypothesize that there will not be a significant difference in the pain scores of these two groups in opioid naïve patients.
Key facts
- Study ID
- NCT03922620
- Run by
- Geisinger Clinic
- People needed
- 1
- Starts
- 2020-01-23
- Expected to finish
- 2021-06-30
- Last updated by the study team
- 2023-02-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients 18 years of age or older
- Patients undergoing elective primary ankle or hindfoot surgery (ankle arthrodesis, subtalar arthrodesis, triple arthrodesis, total ankle arthroplasty, peroneal tendon debridement/transfer, Cavus Reconstruction, Medial Displacement Calcaneal Osteotomy, Dwyer Osteotomy)
You may not qualify if…
- Patients who are undergoing revision surgical procedure
- Patients who have taken opioid pain medications in the past 3 months prior to surgical procedure
- Patients who have allergies to any of the medications or components of medications investigated in the study
- Patients currently incarcerated
- Patients who cannot read and speak English
Where it is running
- Geisinger Woodbine — Danville, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.